These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Blastic plasmacytoid dendritic cell neoplasm with a history of cytopenia: A case report. Yan M; Wang W; Cen X; Wang L; Sun Y; Wang B; Ou J; Nong L; Ren H; Zhu P; Wang M Diagn Cytopathol; 2020 Nov; 48(11):1102-1106. PubMed ID: 32374950 [TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations. El Hussein S; Wang W Br J Haematol; 2023 Mar; 200(5):545-555. PubMed ID: 36606610 [TBL] [Abstract][Full Text] [Related]
7. Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin. Batta K; Bossenbroek HM; Pemmaraju N; Wilks DP; Chasty R; Dennis M; Milne P; Collin M; Beird HC; Taylor J; Patnaik MM; Cargo CA; Somervaille TCP; Wiseman DH Leukemia; 2021 Nov; 35(11):3299-3303. PubMed ID: 33833384 [No Abstract] [Full Text] [Related]
8. Chronic myelomonocytic leukemia transdifferentiation landscape: From histiocytosis to blastic plasmacytoid dendritic cell neoplasm. Antherieu G; Donzel M; Balme B; Traverse-Glehen A; Heiblig M Am J Hematol; 2023 Aug; 98(8):1343-1345. PubMed ID: 36785518 [No Abstract] [Full Text] [Related]
9. Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms. Patnaik MM; Lasho T; Howard M; Finke C; Ketterling RL; Al-Kali A; Pardanani A; Droin N; Gangat N; Tefferi A; Solary E Blood Cancer J; 2018 Aug; 8(9):82. PubMed ID: 30190511 [No Abstract] [Full Text] [Related]